CompletedNCT01338298
Aripiprazole for High Prolactin Levels in Women With Schizophrenia
About this title
Read the official source — NCT01338298Medication studyAges 18–50United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- CatonsvilleSee all locations and recruitment
Study information
Study start dateStarted: January 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT01338298
- Official title
Show the full official title
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Catonsville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole and Placebo.
Who was this study for?
Listed age limits: 18 years to 50 years.
